A 2-year-old boy presents with coarse facial features, gingival hyperplasia, developmental delay, and dysostosis multiplex on skeletal survey. Urine glycosaminoglycans are normal. Fibroblasts cultured from skin biopsy show characteristic inclusion bodies. The structure marked **C** in the diagram (mannose-6-phosphate tag) is absent from lysosomal hydrolases due to deficiency of the enzyme that catalyzes its formation. Which of the following best explains the pathophysiology of this patient's condition?

Explanation

## Why option 1 is correct The structure marked **C** — mannose-6-phosphate (M6P) — is the molecular "ZIP CODE" that directs newly synthesized lysosomal hydrolases to lysosomes. In I-cell disease (mucolipidosis II), deficiency of N-acetylglucosamine-1-phosphate transferase (GlcNAc phosphotransferase, encoded by GNPTAB gene) prevents phosphorylation of mannose residues on N-linked oligosaccharides of soluble lysosomal enzymes. Without the M6P tag, lysosomal hydrolases are not recognized by M6P receptors in the cis-Golgi and are therefore misdirected into the extracellular space and secreted into plasma — paradoxically, this high plasma level of lysosomal enzymes is diagnostic. Inside cells, the absence of these hydrolases in lysosomes results in accumulation of undegraded substrates, leading to the characteristic inclusion bodies visible in fibroblasts (hence "I-cells"). This pathophysiology is the defining feature of I-cell disease (Harper 32e Ch 47; Robbins 10e Ch 6). ## Why each distractor is wrong - **Option 2**: N-linked glycosylation itself is NOT blocked in I-cell disease; the oligosaccharides are synthesized normally in the ER. The defect is specifically in the phosphorylation of mannose residues in the Golgi — a post-translational modification, not a block in the N-linked pathway itself. - **Option 3**: O-linked glycosylation is not involved in lysosomal enzyme targeting. The M6P tag is derived from N-linked oligosaccharides, not O-linked chains. O-linked glycosylation occurs on different proteins and serves different functions. - **Option 4**: Lysosomal membrane fusion is intact in I-cell disease. The problem is not at the lysosomal membrane level but at the level of enzyme sorting and trafficking in the Golgi — the hydrolases never reach the lysosomes in the first place because they lack the M6P targeting signal. **High-Yield:** I-cell disease = defective M6P tagging → lysosomal enzymes secreted into plasma (diagnostic) → substrates accumulate in lysosomes → inclusion bodies. Urine GAGs are NORMAL (unlike MPS), which is a key distinguishing feature. [cite: Harper 32e Ch 47; Robbins 10e Ch 6]